QR Code link to References to Poster

Welcome to the link for my poster at the ASM 2014 Meeting.

I can be reached for more information at aswani.vijay@marshfieldclinic.org. 

References to Poster presented at ASM 2014

1. Abedon ST1, Thomas-Abedon C, Thomas A, Mazure H. Bacteriophage prehistory: Is or is not Hankin, 1896, a phage reference? Bacteriophage. 2011 May;1(3):174-178.
2. Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 55, 64
3. Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 64
4. Raettig, H. 1958. Bakteriophagie 1917 bis 1956, Teil I and II, Gustav Fischer Verlag Stuttgart
5. Raettig H. 1967. Bakteriophagie 1957 – 1965. , Gustav Fischer Verlag Stuttgart.
6. Brussow H. Phage Therapy: Quo Vadis? Clinical Infectious Diseases 2014; 58(4): 535-536
7. Hankin ME. Les microbes des riviíres de l'Inde. Ann Inst Pasteur (Paris) 1896;10:175–176.
8. Twort FW. An investigation on the nature of ultramicroscopic viruses. Lancet. 1915;2:1241–1243
9. d'Hérelle F. Sur un microbe invisible antagoniste des bacilles dysentériques. C R Acad Sci Ser D. 1917;165:373–375.
10. Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 82-96
11. Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 114
12. Chanishvili, N. A Literature Review of the Practical Application of Bacteriophage Research.Nova Biomedical Books, NY.2012. Preface.
13. Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 125-144
14. Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 158

[15] Abedon, ST, Kuhl, SJ, Blasdel, BG, Kutter, EM. Phage Treatment of Human Infections. Bacteriophage 1:2, 66-85. 2011

[16] Summers, C. 1999 Felix d’Herelle and the Origins of Molecular Biology. Yale University Press. Page 206

[17] Ruska H. Über die Sichtbarmachung der bakteriophagen Lyse im Übermikroskop. Naturwissenschaften. 1940;28:45–6. Ruska H. Über die Sichtbarmachung der bakteriophagen Lyse im Übermikroskop. Naturwissenschaften. 1940;28:45–6.

[18] Pfankuch E, Kausche GA. Isolierung und übermikroskopische Abbildung eines Bakteriophagen. Naturwissenschaften. 1940;28:46.

[19] 14

[20] Sanger, F.; Air, G. M.; Barrell, B. G.; Brown, N. L.; Coulson, A. R.; Fiddes, J. C.; Hutchison, C. A.; Slocombe, P. M.; Smith, M. (1977). "Nucleotide sequence of bacteriophage ΦX174 DNA". Nature 265 (5596): 687–95.

[21] Thiel K. 2004. Old dogma, new tricks—21st Century phage therapy Nature Biotechnology 22(1): 31-36. See Table 1 on page 35.

[22] Smith, Hamilton O.; Hutchison, Clyde A.; Pfannkoch, Cynthia; Venter, J. Craig (2003). "Generating a Synthetic Genome by Whole Genome Assembly: ΦX174 Bacteriophage from Synthetic Oligonucleotides". Proceedings of the National Academy of Sciences 100 (26): 15440–5.

[23] Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005;49:2874–2878.

[24] Davison, WC. 1922T he bacteriolysaant Therapy of Bacillary Dysentery in Children. American Journal of Diseases of Children 23:531-534.

[25] Spence RC, McKinley EB. 1924. The Therapeutic Value of the Bacteriophage in Treatment of Bacillary Dysentery. Southern Medical Journal 17 (8): 563-571

[26] Larkum, NW. 1929. Bacteriophage From a Public Health Standpoint. American Journal of Public Health 19: 31-36

[27] Schultz, EW. 1932. Bacteriophage: possible therapeutic aid in dental infections. Journal of Dental Research 12: 295-310.

[28] Straub, ME and Applebaum M. 1933. Studies on commercial bacteriophage products. JAMA 100: 110-113

[29] Eaton MD and Bayne-Jones S. 1934  Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA. 103(23):1769-1776.

[30] Eaton MD and Bayne-Jones S. 1934  Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA103(24):1847-1853.

[31] Eaton MD and Bayne-Jones S. 1934. Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA. 103(25):1934-1939.

[32] Krueger AP and Scribner EJ. 1941. The Bacteriophage: Its Nature and its Therapeutic Use. JAMA 116 (19): 2160-2167.

[33] Krueger AP and Scribner EJ. 1941. The Bacteriophage: Its Nature and its Therapeutic Use. JAMA 116 (20): 2269-2277.

[34] Kutter, E., and A. Sulakvelidze. 2005. Bacteriophages: biology and applications. CRC Press, Inc., Boca Raton, Fla. Page 396.

[35] Kutter, E., and A. Sulakvelidze. 2005. Bacteriophages: biology and applications. CRC Press, Inc., Boca Raton, Fla. Page 398.

[36] Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009;18:237–243